New Guidance on Mitigating Infection Risk During Nebulization
The COPD Foundation Nebulizer Consortium’s statement provides recommendations for preventing the spread of respiratory illnesses in health care settings and home environments.
The COPD Foundation Nebulizer Consortium’s statement provides recommendations for preventing the spread of respiratory illnesses in health care settings and home environments.
Infection control for clinicians and patients when delivering nebulized medications has become a serious concern in critical care units during the COVID-19 pandemic.
The AARC has released its updated aerosol delivery guides to help respiratory therapists, patients and other medical professionals stay up-to-date on the latest devices.
For the past three decades, the marketplace has evolved to provide inhaled medications that are more effective and easier to use.
Read MoreIn 1906, Pari Respiratory began working with whirlpool baths to help people who had respiratory diseases.
Read MoreResMed Corp, Poway, Calif, introduces the VPAP III ST-A, which offers unprecedented flexibility for effective noninvasive ventilation.
Read More